Ribomic Inc. (TYO:4591)

Japan flag Japan · Delayed Price · Currency is JPY
86.00
0.00 (0.00%)
Apr 17, 2026, 3:30 PM JST
Market Cap4.67B +0.7%
Revenue (ttm)750.00K -64.4%
Net Income-1.04B
EPS-22.12
Shares Out54.31M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume753,000
Average Volume1,188,250
Open88.00
Previous Close86.00
Day's Range86.00 - 89.00
52-Week Range72.00 - 141.00
Beta0.21
RSI43.16
Earnings DateMay 13, 2026

About Ribomic

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. The company develops drugs for wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma, as well as separating agents for affinity purification of human IgG and Fc-fusion proteins. The company was incorporated in 2003 and is headquartered in Tokyo, Japan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 25
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4591
Full Company Profile

Financial Performance

Financial Statements